Zeng H et al
All product names, logos, and brands mentioned in this release are the property of their respective owners
Bottom line: Consistent tracking turns guesswork into actionable insights, helping you and your provider fine-tune your treatment plan for the best results
GLP-1s are used to treat a wide range of conditions, including type 2 diabetes, obesity, sleep apnea, chronic kidney disease, a form of fatty liver disease called MASH and risk reduction related to cardiovascular events
The demand is perpendicular to rising obesity and diabetes cases, with the 2025 World Obesity Atlas projecting that the total number of adults living with obesity will increase by around 115 percent by 2030
Your clinician will individualize timing based on your baseline health, medication changes, and your response